Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System

The MIB-1 index is an important risk factor for progression-free survival (PFS) in pituitary adenoma (PA). Preoperatively, the MIB-1 index is not available in the decision-making process. A preoperative method regarding MIB-1 index estimation in PA has not been evaluated so far. Between 2011 and 2021, 109 patients with tumor morphology data, MIB-1 index data, and inflammatory and pituitary hormone laboratory values underwent surgery for PA. An MIB-1 index cutoff point (>= 4/<4%) determines the probability of PFS in completely resected PA. An elevated MIB-1 index (>= 4%) was present in 32 cases (29.4%) and was significantly associated with increased IGF-1, age <= 60, increased ACTH, and increased fibrinogen levels in the multivariable analysis. A scoring system (FATE) using preoperative IGF-1, age, ACTH, and plasma fibrinogen level enables the estimation of the MIB-1 index (sensitivity 72%, specificity 68%). The FATE score is also significantly associated with the time to PA progression after the complete resection of the PA. We propose the FATE score to preoperatively estimate the risk of an elevated MIB-1 index (>= 4%), which might enable tailoring to medical decision-making, and follow-up interval scheduling, as well as inform future studies analyzing proliferative activities.

Automated summary

The MIB-1 index is an important risk factor for progression-free survival in pituitary adenoma. A preoperative method for estimating the MIB-1 index has not been evaluated. The FATE score using preoperative IGF-1, age, ACTH, and plasma fibrinogen level enables the estimation of the MIB-1 index and can be used to assess the risk of an elevated MIB-1 index.